<DOC>
	<DOCNO>NCT01773382</DOCNO>
	<brief_summary>The study aim explore non-pharmacological treatment IgA nephropathy weight reduction . The investigator hypothesize benefit weight loss may reduce proteinuria .</brief_summary>
	<brief_title>The Effects Weight Reduction IgA Nephropathy</brief_title>
	<detailed_description>This prospective randomized study adult IgA nephropathy . The investigator enrol 30 patient proteinuria exceeds 1 g per day biopsy proven IgA nephropathy . The experimental arm recieves non-pharmacological treatment , weight reduction protocol . All patient arm must reduce body weight 3-5 % baseline protocol . Another arm control group recieves standard treatment IgA nephropathy include ACEIs/ARBs blood pressure control ( target &lt; 130/80 mmHg ) . The primary outcome proteinuria level . The secondary outcome cytokine inflammatory marker level include interleukin-6 , resistin , adiponectin , leptin monocyte chemoattractant protein-1 .</detailed_description>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Glomerulonephritis , IGA</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<criteria>Biopsyproven IgA nephropathy body mass index 23 Kg/m2 24 hour urine protein 1 g estimate GFR 20 ml/min pregnancy lactation rapidly renal function decline crescent formation renal biopsy 10 %</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>